Posted by Michael Wonder on 23 Mar 2017
Public summary document for Keytruda (pembrolizumab)
22 March 2017 - The public summary document for pembrolizumab for the treatment of patients with non-small-cell lung cancer from the November 2016 PBAC meeting is now available.
